Cystic fibrosis drug wins approval of FDA advisory panel
from The New York Times
A federal advisory committee recently recommended approval of a drug from Vertex Pharmaceuticals that might eventually help nearly half of patients with cystic fibrosis. The advisory committee to the Food and Drug Administration voted 12 to 1 that the drug, which Vertex plans to call Orkambi, was safe and effective enough to be approved. The F.D.A. is supposed to decide by July 5.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063